Overview

Amlodipine Diabetic Hypertension Efficacy Response Trial

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of <130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine
Criteria
Inclusion Criteria:

- Documented evidence of Type 2 diabetes as defined by the ADA guidelines and documented
evidence of Hypertension (various SBP/DBP ranges).

Exclusion Criteria:

- A previous history or intolerance or hypersensitivity to calcium channel blockers,
ARBs or ACE inhibitors.